Physician profile
Gary Witucki
NPI 1184699472
$3,121.57
in general payments reported to CMS, 2019-2025
19 companies · $1,446 in 2025
The $1,446 reported for 2025 was more than what 87% of Undersea and Hyperbaric Medicine (Preventive Medicine) providers received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.99 · 2020: $39.77 · 2021: $108 · 2022: $75.54 · 2023: $774 · 2024: $587 · 2025: $1,446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,012 · Travel and Lodging: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,012.15 |
| Travel and Lodging | $794.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $1,108.76 | 2024-2025 | 3m Cavilon, Prevena, Activ.A.C. |
| Kci USA, INC. | $634.75 | 2023 | Snap, V.A.C. Dermatac, 3m Coban |
| Organogenesis INC. | $482.09 | 2019-2025 | Puraply Am, Puraply Wound Matrix, Puraply Franchise |
| Smith+Nephew, INC. | $346.98 | 2023-2025 | Collagenase Santyl, Allevyn Life L 15.4x15.4 Ctn10, Pico |
| Convatec INC. | $68.16 | 2024-2025 | |
| Kerecis Limited | $67.23 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Tactile Systems Technology INC | $65.74 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Novo Nordisk INC | $42.60 | 2022 | |
| Medtronic, INC. | $40.22 | 2025 | Venaseal |
| Hydrofera LLC | $37.43 | 2022-2025 | Hydrofera Blue |
| Integra Lifesciences Corporation | $36.40 | 2019 | |
| Mimedx Group, INC. | $28.16 | 2025 | |
| Medline Industries Lp | $27.41 | 2025 | |
| Urgo Medical North America, LLC | $25.21 | 2025 | Urgoclean Ag |
| Molnlycke Health Care US, LLC | $25.18 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.42 | 2023 | Dalvance |
| Bsn Medical INC | $21.42 | 2025 | |
| Paratek Pharmaceuticals, INC. | $21.40 | 2025 | Nuzyra |
| Lifenet Health | $20.01 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Witucki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.